Gan & Lee Pharmaceuticals' high P/S ratio may not be justifi...

Gan & Lee Pharmaceuticals' high P/S ratio may not be justified due to its slow revenue growth and the industry's better growth forecast. Investors may be disappointed if the P/S falls in line with the growth outlook, posing a significant risk of share price decline.